FDA 510(k)
FDA class 2
Substantially Equivalent
🇨🇦 Canada
IGX PLEX CELIAC QUALITATIVE ASSAY
K Number: K102490
·
Decision Jun 2, 2011
Classifications
1
FEI Numbers
19
Registration Numbers
19
Same Product Code
39
Applicant Total
2
Review Days
275
Research this 510(k) in seconds
The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.
Free to try · every answer cites its records
Basic Information
- Device Name
- IGX PLEX CELIAC QUALITATIVE ASSAY
- K Number
- K102490
- Device Class
- FDA class 2
- Clearance Type
- Traditional
- Regulation Number
- 866.5660
- Medical Specialty
- Immunology
- Decision
- Substantially Equivalent
- Statement or Summary
- Summary
- Applicant
- Sqi Diagnostics Systems
- Date Received
- August 31, 2010
- Decision Date
- June 2, 2011
- Product Code
- MVM
- Advisory Committee
- Immunology
- Review Advisory Committee
- IM
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| MVM | Autoantibodies, Endomysial(Tissue Transglutaminase) | FDA class 2 | Immunology |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (MVM), ordered by most recent decision date.
Aptiva Celiac Disease IgG Reagent
FDA 510(k)
FDA Class 2
·Immunology
Aptiva Celiac Disease IgA Reagent
FDA 510(k)
FDA Class 2
·Immunology
EliA Celikey IgG Immunoassay; EliA GliadinDP IgA Immunoassay; EliA GliadinDP IgG Immunoassay
FDA 510(k)
FDA Class 2
·Immunology
EUROIMMUN Anti-tissue Transglutaminase ELISA (IgA), EUROIMMUN Anti-tissue Transglutaminase ELISA (IgG)
FDA 510(k)
FDA Class 2
·Immunology
IG_PLEX CELIAC DGP PANEL
FDA 510(k)
FDA Class 2
·Immunology
IMMULISA ENHANCED CELIAC FUSION (TTG/DGP) IGA/IGG ANTIBODY ELISA
FDA 510(k)
FDA Class 2
·Immunology
Other Clearances by Sqi Diagnostics Systems
| K Number | Device Name | ||
|---|---|---|---|
| K083080 | IGX PLEX RHEUMATOID ARTHRITIS (RA) ASSAY AND SQIDWORKS DIAGNOSTICS PLATFORM | Oct 29, 2009 | Substantially Equivalent |